Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 11—November 2002
Research

Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family

Francis Drobniewski*Comments to Author , Yanina Balabanova*, Michael Ruddy*, Laura Weldon*, Katya Jeltkova†, Timothy Brown*, Nadezdna Malomanova‡, Elvira Elizarova‡, Alexander Melentyey§, Ebgeny Mutovkin§, Svetlana Zhakharova‡, and Ivan Fedorin‡
Author affiliations: *Guy's King's and St Thomas' Medical School, King's College Hospital, London, United Kingdom; †Central Tuberculosis Research Institute, Moscow, Russian Federation; ‡Samara Oblast Dispensary, Samara City, Russian Federation; §Samara Prison TB Service, Samara City, Russian Federation;

Main Article

Table 2

Patient factors associated with rifampin- and isoniazid-resistant isolatesa

Factor Rifampin resistance (n=78) Isoniazid resistance (n=66)
Age p<0.05b p>0.05
Known prisoner RR 1.68,b CI 1.29 to 2.18 RR 1.36, CI 0.97 to 1.89
Known previous treatment RR 1.71,b CI 1.07 to 2.74 RR=2.04,b CI 1.01 to 4.10

aRR, risk ratio; CI, confidence interval.
bStatistically significant.

Main Article

Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external